Manifold Partners’s Pfizer PFE Stock Holding History

Manifold Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,615	Closed	-$115K	–	107
2015 Q2	$115K	Sell	3,615 -32,253	-90%	-$1.05M	0.1%	51
2015 Q1	$1.18M	Sell	35,868 -17,452	-33%	-$555K	1.17%	28
2014 Q4	$1.58M	Sell	53,320 -73,780	-58%	-$2.12M	1.6%	21
2014 Q3	$3.57M	Buy	127,100 +29,186	+30%	+$819K	2.39%	10
2014 Q2	$2.76M	Buy	+97,914	New	+$2.79M	1.6%	33
2013 Q4	–	Sell	-113,828	Closed	-$3.1M	–	136
2013 Q3	$3.1M	Buy	113,828 +1,366	+1%	+$37.2K	1.99%	22
2013 Q2	$2.99M	Buy	+112,462	New	+$3.11M	2.1%	25

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Manifold Partners's PFE Position: Q3 2015 in Review

Manifold Partners sold out of Pfizer (PFE) in Q3 2015, closing a stake of 3,615 shares — an estimated $115K sold.

Manifold Partners first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $3.57M in Q3 2014. 1,880 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

Manifold Partners reported no remaining Pfizer position as of Q3 2015 after selling out during the quarter.
Manifold Partners sold 3,615 Pfizer shares in Q3 2015, an estimated $115K.
Manifold Partners first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
Manifold Partners's Pfizer position peaked at $3.57M in Q3 2014.
1,880 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Manifold Partners's 13F filing for Q3 2015, filed 4 Nov 2015.